Related Experiment Video
Updated: Mar 6, 2026

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
Acute memory deficits in chemotherapy-treated adults
Oana C Lindner1,2, Andrew Mayes1, Martin G McCabe3
1a Division of Neuroscience and Experimental Psychology, School of Biological Sciences , University of Manchester , Manchester , UK.
Chemotherapy may acutely impair memory consolidation, leading to faster forgetting in cancer patients. This study suggests chemotherapy selectively impacts slow long-term memory consolidation, with potential clinical implications for cognitive function.
Area of Science:
- Neuroscience
- Oncology
- Cognitive Psychology
Background:
- Existing research on memory consolidation in amnesia and epilepsy is inconclusive regarding rapid vs. slow long-term memory dissociation.
- Cancer treatments are known to cause lasting memory deficits, but their acute effects on synaptic consolidation remain unclear.
Purpose of the Study:
- To investigate the hypothesis that cancer treatment acutely impairs slow synaptic consolidation.
- To assess the immediate impact of chemotherapy on memory learning, forgetting, and retrieval processes.
Main Methods:
- A novel list-learning task, based on the Rey Auditory Verbal Learning Test, was administered to 10 cancer patients and their matched controls.
- Memory performance was evaluated before and one day after the patients' first chemotherapy treatment, measuring learning, forgetting, and retrieval.
Main Results:
- Cancer patients demonstrated significantly accelerated forgetting over 24 hours after chemotherapy compared to their baseline performance and controls.
- An increase in intrusions post-treatment suggested potential deficits in memory retrieval.
Conclusions:
- The findings support the hypothesis that chemotherapy acutely impairs slow synaptic consolidation, leading to accelerated forgetting.
- Despite a small sample size, the results indicate a potentially significant clinical impact of chemotherapy on cognitive function, warranting further investigation with larger cohorts.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Alzheimer's Disease: Treatment
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

